These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5252285)

  • 81. [A glance at the anti-tuberculosis organization in Rumania].
    Omodei Zorini A
    Minerva Med; 1967 Aug; 58(65):varia 995+. PubMed ID: 6054087
    [No Abstract]   [Full Text] [Related]  

  • 82. [BCG vaccination of young children in maternity hospitals and medical dispensaries].
    Bărbulescu R; Mihăilescu P; Calciu B; Alexandrescu D; Amzărescu E; Petrovici C; Sîrbu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):241-2. PubMed ID: 6278568
    [No Abstract]   [Full Text] [Related]  

  • 83. [18 years of application of BCG vaccine in medical practice].
    Bahov J
    Rev Tuberc Pneumol (Paris); 1969; 33(4):557-9. PubMed ID: 5382435
    [No Abstract]   [Full Text] [Related]  

  • 84. [Tuberculosis control by the Swiss Union against Tuberculosis in Tanzania, a 5-year plan].
    Ott A
    Schweiz Rundsch Med Prax; 1973 Oct; 62(43):1294-7. PubMed ID: 4761459
    [No Abstract]   [Full Text] [Related]  

  • 85. BCG against tuberculosis: 1996.
    Lenner R
    Conn Med; 1996 Jun; 60(6):329-34. PubMed ID: 8706426
    [No Abstract]   [Full Text] [Related]  

  • 86. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
    Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
    Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tuberculosis control, without protection from BCG.
    John TJ
    Indian Pediatr; 2000 Jan; 37(1):9-18. PubMed ID: 10745384
    [No Abstract]   [Full Text] [Related]  

  • 88. [A glance at antituberculosis organizations in Rumania].
    Omodei Zorini A
    Lotta Tuberc; 1967; 37(3):198-200. PubMed ID: 5252285
    [No Abstract]   [Full Text] [Related]  

  • 89. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
    Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
    FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.